Tablets & capsules, liquid-dosage forms. Inhalables & intranasals. Injectables: intravenous, intramuscular & subcutaneous. Nanotechnology, dissolvable films and tablets & radio frequency transdermal drug delivery.
March 4, 2010 ePT--the Electronic Newsletter of Pharmaceutical Technology
Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.
 |
 | March 1, 2010 By:Ashok R. Patel, Pradeep R. Vavia Pharmaceutical Technology Europe
A new kind of gastro-retentive dosage form for drugs with poor aqueous solubility was developed and evaluated, with the aim of achieving gastro-retention.
 |
February 25, 2010 ePT--the Electronic Newsletter of Pharmaceutical Technology
Merck To Eliminate 15,000 jobs; Tauzin Stepping Down At PhRMA; And More.
 |
February 18, 2010 By:Erik Greb ePT--the Electronic Newsletter of Pharmaceutical Technology
RUSNANO, a corporation established by the Russian government to foster the development of nanotechnology, launched a project last week to manufacture targeted-delivery nanodrugs to treat malignant neoplasms.
 |
February 18, 2010 ePT--the Electronic Newsletter of Pharmaceutical Technology
Abbott Completes Acquisition Of Solvay; Merck Names President of Consumer Healthcare; And More.
 |
February 11, 2010 ePT--the Electronic Newsletter of Pharmaceutical Technology
VaxGen Shareholders Reject OXiGENE Merger; Roche Creates Research Hub In Singapore; And More.
 |
February 5, 2010 By:Stephanie Sutton Pharmaceutical Technology Europe
Capsules that can release their contents at a selected temperature have been developed by researchers in France, and could lead to the development of therapeutic agents that are applied to the skin and triggered locally by rubbing.
 |
February 4, 2010 ePT--the Electronic Newsletter of Pharmaceutical Technology
Cephalon Buys Mepha; BASi's CEO Retires; and More.
 |
February 2, 2010 By:Billy Tauzin Pharmaceutical Technology
When it comes to healthcare rform, we must not overlook investment in innovative technologies.
 |
|